Version 4.0.200811







This is the complete description of the cell line that you requested. By selecting a generic term (e.g. SPECIES) you will go to the corresponding list of controlled terms, while by selecting a specific term you will go to the list of corresponding cell line names.

HEP-G2 (human, liver, carcinoma, hepatocellular)


SPECIES: human
TISSUE/ORGAN: liver
TUMOR: carcinoma, hepatocellular

DSMZ catalog code: ACC 180
Morphology: adherent, epithelial-like cells growing as monolayers and in small aggregates
Description: human hepatocellular carcinoma established from the tumor tissue of a 15-year-old Argentine boy with hepatocellular carcinoma in 1975; cell line is patented; cells were described to not harbor a hepatitis B virus genome; cells reportedly produce a variety of proteins: alpha-fetoprotein, albumin, alpha2-macroglobulin, alpha1-antitrypsin, transferrin, alpha1-antichymotrypsin, haptoglobin, ceruloplasmin, plasminogen, complement (C3, C4), C3 activator, fibrinogen, alpha1-acid glycoprotein, alpha2-HS glycoprotein, ss-lipoprotein, retinol binding protein confirmed as human with IEF of AST, MDH
Viruses: ELISA: reverse transcriptase negative; PCR: EBV-, HBV-, HCV-, HHV-8-, HIV-, HTLV-I/II-
Depositor: obtained from ATCC (HB 8065), Rockville, Maryland, USA
General Restrictions

Available in the following LABORATORY:

Availability in cell line catalogues: ATCC: HB 8065

Bibliographic references:





For information, get in touch with:

Istituto Nazionale per la Ricerca sul Cancro,
c/o Centro Biotecnologie Avanzate, Torre B - Piano 2
Largo Rosanna Benzi, 10 - I-16132 Genova - Italy Tel: +39-0105558-289, Fax: +39-0105558-293
Email: assunta.manniello@istge.it